%PDF-1.4
%
121 0 obj
<>
endobj
180 0 obj
<>/Font<>>>/Fields[]>>
endobj
118 0 obj
<>
endobj
68 1 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-11-27T11:24:16Z
2024-03-28T03:56:06-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T03:56:06-07:00
application/pdf
Heather
2002-853.jan
uuid:e9c7abb6-1dd1-11b2-0a00-820827bd7700
uuid:e9c7abb9-1dd1-11b2-0a00-900000000000
endstream
endobj
105 0 obj
<>
endobj
107 0 obj
<>
endobj
106 0 obj
<>
endobj
122 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 79 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 81 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 83 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 85 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 87 0 R/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 89 0 R/Type/Page>>
endobj
26 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 91 0 R/Type/Page>>
endobj
29 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 93 0 R/Type/Page>>
endobj
37 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 95 0 R/Type/Page>>
endobj
65 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 97 0 R/Type/Page>>
endobj
222 0 obj
[226 0 R]
endobj
223 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 61 714.5293 Tm
[(3.)-875.1 (Campanacci M. Pigmented villonodular synovitis, tenosynovitis,)]TJ
1.675 -1.25 Td
[(bursitis. In: Campanacci M, editor)54.8 (. Bone and soft tissue tumors.)]TJ
0 -1.25 TD
[(New )36.8 (Y)99.8 (ork: Springer)19.7 (-V)110.8 (erlag; 1999:1289-306.)]TJ
-1.675 -1.25 Td
[(4.)-875.1 (Ray RA, Morton CC, Lipinski KK, Corson JM, Fletcher JA.)]TJ
1.675 -1.25 Td
(Cytogenetic evidence of clonality in a case of pigmented )Tj
T*
(villonodular synovitis. Cancer 1991;67:121-5.)Tj
0 Tc -1.675 -1.25 Td
[(5.)-875 (Rowlands CG, Roland B, Hwang )17.7 (WS, Sevick RJ. Dif)17.8 (fuse-variant)]TJ
-0.00011 Tc 1.675 -1.25 Td
(tenosynovial giant cell tumor: a rare and aggressive lesion. Hum)Tj
T*
(Pathol 1994;25:423-5.)Tj
-1.675 -1.25 Td
[(6.)-875.1 (Abdul-Karim FW)91.7 (, el-Naggar )54.8 (AK, Joyce MJ, Makley JT)73.9 (, Carter JR.)]TJ
1.675 -1.25 Td
[(Dif)17.7 (fuse and localized tenosynovial giant cell tumor and pigmented)]TJ
T*
(villonodular synovitis: a clinicopathologic and flow cytometric)Tj
T*
[(DNA)-220.2 (analysis. Hum Pathol 1992;23:729-35.)]TJ
-1.675 -1.25 Td
[(7.)-875.1 (Bullough PG, Bansal M. )17.7 (The dif)17.7 (ferential diagnosis of geodes.)]TJ
1.675 -1.25 Td
[(Radiol Clin North )54.8 (Am 1988;26:1)36.8 (165-84.)]TJ
-1.675 -1.25 Td
[(8.)-875.1 (Nilsonne U, Mober)17.7 (ger G. Pigmented villonodular synovitis of)]TJ
1.675 -1.25 Td
[(joints. Histological and clinical problems in diagnosis. )54.8 (Acta Orthop)]TJ
0 Tc T*
(Scand 1969;40:448-60.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(9.)-875.1 (Jer)17.7 (gesen HE, Mankin HJ, Schiller )54.8 (AL. Dif)17.7 (fuse pigmented )]TJ
1.675 -1.25 Td
(villonodular synovitis of the knee mimicking primary bone)Tj
T*
[(neoplasms. )54.8 (A)-220.1 (report of two cases. J Bone Joint Sur)17.7 (g )54.8 (Am)]TJ
0 Tc 0 Tw T*
(1978;60:825-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(10.)-875.1 (Andersen JA, Ladefoged C. )54.8 (A)-220.1 (case of aggressive pigmented )]TJ
2.175 -1.25 Td
[(villonodular synovitis. )54.8 (Acta Orthop Scand 1988;59:467-70.)]TJ
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Chung SMK, Janes JM. Dif)17.7 (fuse pigmented villonodular synovitis)]TJ
2.1381 -1.25 Td
(of the hip joint: Review of the literature and report of four cases. )Tj
0 Tc T*
[(J Bone Joint Sur)17.8 (g )54.8 (Am 1965;47:293.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(12.)-875.1 (Scott PM. Bone lesions in pigmented villonodular synovitis. J Bone)]TJ
0 Tc 2.175 -1.25 Td
[(Joint Sur)17.8 (g Br 1968;50:306-1)36.9 (1.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(13.)-875.1 (McMaster PE. Pigmented villonodular synovitis with invasion of)]TJ
2.175 -1.25 Td
[(bone. J Bone Joint Sur)17.7 (g )54.8 (Am 1960;42:1)36.8 (170-83.)]TJ
-2.175 -1.25 Td
[(14.)-875.1 (Darling JM, Glimcher LH, Shortkrof)17.7 (f S, )54.8 (Albano B, Gravallese EM.)]TJ
2.175 -1.25 Td
(Expression of metalloproteinases in pigmented villonodular)Tj
T*
(synovitis. Hum Pathol 1994;25:825-30.)Tj
-2.175 -1.25 Td
[(15.)-875.1 (Darling JM, Goldring SR, Harada )36.8 (Y)128.9 (, Handel ML, Glowacki J,)]TJ
2.175 -1.25 Td
(Gravallese EM. Multinucleated cells in pigmented villonodular)Tj
T*
(synovitis and giant cell tumor of tendon sheath express features of)Tj
T*
[(osteoclasts. )54.9 (Am J Pathol 1997;150:1383-93.)]TJ
-2.175 -1.25 Td
[(16.)-875.1 (Neale SD, Kristelly R, Gundle R, Quinn JM, )54.8 (Athanasou NA. Giant)]TJ
2.175 -1.25 Td
(cells in pigmented villonodular synovitis express an osteoclast)Tj
T*
(phenotype. J Clin Pathol 1997;50:605-8.)Tj
-2.175 -1.25 Td
[(17.)-875.1 (W)79.9 (oessner JF Jr)54.8 (. Matrix metalloproteinases and their inhibitors in)]TJ
2.175 -1.25 Td
[(connective tissue remodeling. F)73.9 (ASEB J 1991;5:2145-54.)]TJ
-2.175 -1.25 Td
[(18.)-875.1 (Matrisian LM. )17.7 (The matrix-degrading metalloproteinases. Bioessays)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(1992;14:455-63.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(19.)-875.1 (V)110.8 (an )17.7 (W)79.9 (art HE, Birkedal-Hansen H. )17.7 (The cysteine switch: a principle)]TJ
2.175 -1.25 Td
(of regulation of metalloproteinase activity with potential )Tj
T*
[(applicability to the entire matrix metalloproteinase gene family)64.8 (.)]TJ
T*
[(Proc Natl )54.8 (Acad Sci USA)-220.2 (1990;87:5578-82.)]TJ
-2.175 -1.25 Td
[(20.)-875.1 (Docherty )54.8 (AJ, Murphy G. )17.7 (The tissue metalloproteinase family and)]TJ
2.175 -1.25 Td
[(the inhibitor )17.7 (TIMP: a study using cDNAs and recombinant)]TJ
0 Tc T*
[(proteins. )54.9 (Ann Rheum Dis 1990;49:469-79.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(21.)-875.1 (Pavlof)17.7 (f N, Staskus PW)91.7 (, Kishnani NS, Hawkes SP)110.7 (. )54.8 (A)-220.1 (new inhibitor)]TJ
2.175 -1.25 Td
[(of metalloproteinases from chicken: ChIMP-3. )54.8 (A)-220.1 (third member of)]TJ
T*
[(the )17.8 (TIMP)-238.2 (family)64.9 (. J Biol Chem 1992;267:17321-6.)]TJ
30.825 67.5 Td
[(22.)-875.1 (W)79.9 (alakovits LA, Moore )17.7 (VL, Bhardwaj N, Gallick GS, Lark MW)91.7 (.)]TJ
2.175 -1.25 Td
(Detection of stromelysin and collagenase in synovial fluid from)Tj
T*
[(patients with rheumatoid arthritis and posttraumatic knee injury)64.8 (.)]TJ
T*
(Arthritis Rheum 1992;35:35-42.)Tj
-2.175 -1.25 Td
[(23.)-875.1 (Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston )17.7 (TE. )17.7 (The)]TJ
2.175 -1.25 Td
(measurement of collagenase, tissue inhibitor of metalloproteinases)Tj
T*
[(\(TIMP\), and collagenase-TIMP)-238.2 (complex in synovial fluids from)]TJ
T*
[(patients with osteoarthritis and rheumatoid arthritis. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 1993;36:372-9.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(24.)-875.1 (Jackson CJ, )54.8 (Arkell J, Nguyen M. Rheumatoid synovial endothelial)]TJ
2.175 -1.25 Td
[(cells secrete decreased levels of tissue inhibitor of MMP)-238.3 (\(TIMP1\).)]TJ
0 Tc T*
(Ann Rheum Dis 1998;57:158-61.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(25.)-875.1 (Miyazaki )17.7 (T)74 (, Sato M, Murata )36.8 (Y)128.9 (, Maeda K, Seo H. Factor\(s\) present)]TJ
2.175 -1.25 Td
(in sera from patients on long-term hemodialysis increase\(s\))Tj
T*
[(mRNAs for collagenase and stromelysin in synovial cells. )54.8 (Am )]TJ
T*
(J Nephrol 1995;15:48-56.)Tj
-2.175 -1.25 Td
[(26.)-875.1 (T)69.9 (empleton NS, Brown PD, Levy )54.8 (A)110.8 (T)74 (, Mar)17.7 (gulies IM, Liotta LA,)]TJ
2.175 -1.25 Td
[(Stetler)19.7 (-Stevenson )17.7 (WG. Cloning and characterization of human)]TJ
T*
(tumor cell interstitial collagenase. Cancer Res 1990;50:5431-7.)Tj
-2.175 -1.25 Td
[(27.)-875.1 (Collier IE, )17.7 (W)39.9 (ilhelm SM, Eisen )54.8 (AZ, et al. H-ras )]TJ
2.175 -1.25 Td
(oncogene-transformed human bronchial epithelial cells \(TBE-1\))Tj
T*
(secrete a single metalloprotease capable of degrading basement)Tj
T*
(membrane collagen. J Biol Chem 1988;263:6579-87.)Tj
-2.175 -1.25 Td
[(28.)-875.1 (W)39.8 (ilhelm SM, Collier IE, Marmer BL, Eisen )54.8 (AZ, Grant GA,)]TJ
2.175 -1.25 Td
[(Goldber)17.7 (g GI. SV40-transformed human lung fibroblasts secrete a)]TJ
T*
[(92-kDa type IV)-257.3 (collagenase which is identical to that secreted by)]TJ
T*
(normal human macrophages. J Biol Chem 1989;264:17213-21.)Tj
-2.175 -1.25 Td
[(29.)-875.1 (Zhang J, Fujimoto N, Iwata K, Sakai )17.7 (T)74 (,)-0.1 ( Okada )36.8 (Y)128.9 (, Hayakawa )17.7 (T)74 (.)-0.1 ( )54.8 (A)]TJ
2.175 -1.25 Td
(one-step sandwich enzyme immunoassay for human matrix )Tj
T*
(metalloproteinase 1 \(interstitial collagenase\) using )Tj
T*
[(monoclonal antibodies. Clin Chim )54.8 (Acta 1993;219:1-14.)]TJ
-2.175 -1.25 Td
[(30.)-875.1 (Fujimoto N, Zhang J, Iwata K, Shinya )17.7 (T)74 (, Okada )36.7 (Y)128.9 (, Hayakawa )17.7 (T)74 (.)-0.1 ( )54.8 (A)]TJ
2.175 -1.25 Td
(one-step sandwich enzyme immunoassay for tissue inhibitor of)Tj
T*
[(metalloproteinases-2 using monoclonal antibodies. Clin Chim )54.8 (Acta)]TJ
0 Tc 0 Tw T*
(1993;220:31-45.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(31.)-875.1 (Fujimoto N, Hosokawa N, Iwata K, Shinya )17.7 (T)74 (, Okada )36.8 (Y)128.9 (, Hayakawa)]TJ
2.175 -1.25 Td
[(T)74 (.)-0.1 ( )54.8 (A)-220.1 (one-step sandwich enzyme immunoassay for inactive)]TJ
T*
(precursor and complexed forms of human matrix metalloproteinase)Tj
T*
[(9 \(92 kDa gelatinase/type IV)-257.3 (collagenase, gelatinase B\) using)]TJ
T*
[(monoclonal antibodies. Clin Chim )54.8 (Acta 1994;231:79-88.)]TJ
-2.175 -1.25 Td
[(32.)-875.1 (Okada )36.8 (Y)128.9 (, Nagase H, Harris ED Jr)54.8 (. Matrix metalloproteinases 1, 2,)]TJ
2.175 -1.25 Td
[(and 3 from rheumatoid synovial cells are suf)17.7 (ficient to destroy)]TJ
T*
(joints. J Rheumatol 1987;14 Special Issue:41-2.)Tj
-2.175 -1.25 Td
[(33.)-875.1 (Kaneko M, )17.7 (T)69.9 (omita )17.7 (T)74 (, Nakase )17.7 (T)74 (, et al. Expression of proteinases and)]TJ
2.175 -1.25 Td
(inflammatory cytokines in subchondral bone regions in the )Tj
T*
(destructive joint of rheumatoid arthritis. Rheumatology Oxford)Tj
0 Tc 0 Tw T*
(2001;40:247-55.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(34.)-875.1 (Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL.)]TJ
2.175 -1.25 Td
(Immunolocalisation studies on six matrix metalloproteinases and)Tj
T*
[(their inhibitors, )17.7 (TIMP-1 and )17.7 (TIMP-2, in synovia from patients with)]TJ
T*
[(osteo- and rheumatoid arthritis. )54.8 (Ann Rheum Dis 1995;54:25-32.)]TJ
-2.175 -1.25 Td
[(35.)-875.1 (Brinckerhof)17.7 (f CE. Joint destruction in arthritis: metalloproteinases in)]TJ
2.175 -1.25 Td
[(the spotlight. )54.8 (Arthritis Rheum 1991;34:1073-5.)]TJ
-2.175 -1.25 Td
[(36.)-875.1 (Goldbach-Mansky R, Lee JM, Hoxworth JM, et al. )54.8 (Active synovial)]TJ
2.175 -1.25 Td
(matrix metalloproteinase-2 is associated with radiographic erosions)Tj
T*
[(in patients with early synovitis. )54.8 (Arthritis Res 2000;2:145-53.)]TJ
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_1 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(Uchibori, et al: MMP)-257.3 (and TIMP)-257.3 (in PVNS)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(119)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.08 396.48 -10.83 re
f*
0.5 w
109.22 59.08 396.48 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
97 0 obj
<>stream
8;Z\5$#[X7%+G5@W:+Q'_o&pQUg$`)5Vt%U<_!Bdd@!cmn\6:-p&+gbrYY%Kf3b`=
m@QVhnBW]KA/S"lEjga'lb5ZA3L+Ug9!1pr0=MN/1Ig".Xh(Fc$EWC$.p=<)iu;ko
"PX4a!=lC"Ol%6)D)-Dkb:"W)kSk*YaPIfqk*^
aCojaBlu)So
WMW%e'Pc@hfFp74\(O-:`f#GM7<^)J4i?g%b-\&.Y[ahicj[AeWOK8VAuMqpW*rWf
23kt+94ZBY`uo_M!,\"T4G=62Q#;qKXB)Mis5jU`4m%F.Ud"J80:Hp,/Wo!I@j?jK
,sm/8>JLhn`f#)^S45I)\_GSDe::Qh\5IO4?_OSMmNV@,6X
3o_sf^0U<4+"`oIM<41Oi0[t@3i&$phtshJ0B+9``7Y)lTLR**=ujuT?CS53f0s>^
gjUaQ>j=OAU`ic56_2"5\_Di+Z*L+H4FoJ]PN6]"ZH6on25Bc21M_s"PasYN`X01(
\Cp7DJJ>0,[N2WH%^\\W$Tj.o@7N.k*GVcQSWP40R]@afaj*H6"iC2Y9)^Hr'2La\
59o$G99L9*]Pb=+=l67O\Dco9CB1<&)R'~>
endstream
endobj
103 0 obj
[/Indexed/DeviceRGB 255 102 0 R]
endobj
102 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
128 0 obj
<>
endobj
124 0 obj
<>
endobj
145 0 obj
<>
endobj
188 0 obj
<>
endobj
125 0 obj
<>
endobj
137 0 obj
<>stream
HT{PSW˽hͭ~nX<"D $<A% F`>ZT;n2n7=tvv윙o~;91[q'Ooo?z.H
XI\pn
7f{ƷY'.m9&ڌ|tLa#q.opw_SKcٕ7]ǍG,BU)b)JqzƲ
V.VIY
g(4\~b}%q2*^zlcVS$F($QpD7%íñi6Tl>-6aا4;Xļ:6_mmb6v'Z[3t1}ˎ
O24U05i*oLpZܴ{7O2cF7"G'NNNC35eaߜ+gϝ
XX]w>8ȑ8JiLd7aex3x%x]?mJ-U٫ 4>Gwey2X12m~QjZ\b3bdc2m-}=Z_iՁ(-`U`
q90'.hTב'іTi&uD,MUj5z:[5
C3(1N̔d255%dD+#0 ha^maMIŝ_x}P?e/?/^]v #aڬDŬjx~-nx+ cYԠ]bR+4U
OUc礉;Eȋk5,, N=q5Q
Q$k`_+r~%""t{M@_xPTz꺤~i}lndDg10C~O ^35uk%:XuFtEv>_w&Dh?Ufkg+3K:j^nb>\xgb2v$feJkns8!87ffR4TŲ9PL}G&_QՃ4KI_%R0/H1]1Z40/ hl6Om>Ja5H
t츒Ԓs6=T:ؚ!hnOmKgHG͜YPhR&sWƶުqmsbЫjU۪(p7ƫ:
yD+٩TƇSqlxHyr@rnhn:#;9W Z|Vd͍_<B5IN&PEJ
Y\۰[bqbbev+{}\O;V]|=j}vV[~z6lyfFaV}oj>3^w E̤{^tr}>H|4aHcWS^[W:k4rs0ϡQb~(ywn0WC.9ClsSHWYh&\iHaOyi]rOȂҏJrux52&0?ȝ w2|R?^CMp|& hE|ַ߽ss6✽,kI_12B6UUZ4Ht#p,b
3H 8~
wHXfXܙc9˜U[M "-Bv!
/n<*7TV4>ZZOp f}]#}%uu@()Vf
0,K/+D+B|G_(] l":y]͟韏>F1n(9k3ou/_c~oYA
jXSrx}ľQN i@G&R! !F݃ciCYN
}:\Wk䤔r7UԝIcu8U|SSczVck[EGQ# HdKl@6aI^^&k